Eurocine Vaccines is a pharmaceutical company. The company develops vaccines using its proprietary technology platform Endocine™, which vaccines are subsequently licensed to partners for further development and commercialization. Development is carried out in cooperation with other companies in the industry. The technology platform Endocine™ is also offered to other companies for development within certain indications. The head office is located in Solna.

Quotes for Eurocine Vaccines AB

Right Now

+/-
-0.065
%
-2,35%
Latest
2.705
High
2.795
Low
2.7
Volume
20 819
Turnover (SEK)
57 762
Value (MSEK)
38,4

Board

CEO

  • Hans Arwidsson

Chairperson of the Board

  • Pierre Morgon

Board

  • Emanuele Montomoli
  • Hans Arwidsson
  • Jan Sandström
  • Pär Thuresson

Videos

Largest Owners

Name Capital % Votes % Date
Thomas Eldered 13,34 13,34 2021-12-31
Avanza Pension 5,17 5,17 2021-12-31
Nordnet Pensionsförsäkring 3,87 3,87 2021-12-31
Jan Kenneth Karjalainen 1,77 1,77 2021-12-31
Kent Olsson 1,30 1,30 2021-12-31
Göran Erlandsson 1,25 1,25 2021-12-31
VisMederi Srl 0,96 0,96 2021-12-31
Robert Grebenstedt 0,89 0,89 2021-12-31
BRL Invest AB 0,89 0,89 2021-12-31
Bo Sjögren 0,89 0,89 2021-12-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Upcoming reports

  • 2022-02-16 Delårsrapport 2022-Q2